Depo-Provera

Depo-Provera Lawsuit — Meningioma Brain Tumor Claims

Women who used Depo-Provera for extended periods have developed meningioma — a serious brain tumor. Although meningiomas are often benign, they require surgery, cause debilitating neurological symptoms, and can transform into malignant tumors. Trial Lawyers United represents women harmed by Depo-Provera-associated meningiomas.

What is Depo-Provera?

Depo-Provera (medroxyprogesterone acetate) is an injectable hormonal contraceptive manufactured by Pfizer. Administered as an intramuscular injection every 12 weeks, Depo-Provera is one of the most widely used reversible contraceptives globally, with millions of doses distributed since FDA approval in 1992.

The mechanism is endocrine: Depo-Provera mimics the hormone progesterone, suppressing ovulation and preventing pregnancy. However, the synthetic hormone carries risks beyond contraceptive efficacy.

Scientific Evidence: Depo-Provera and Meningioma Risk

Multiple epidemiological studies have established a significant association between Depo-Provera use and meningioma development:

• 2024 French National Health Insurance Study: Researchers analyzed data from 4 million women. Extended Depo-Provera use (5+ years) was associated with a 2-fold increased risk of meningioma diagnosis.
• World Health Organization (WHO) 2019 Assessment: WHO classified the meningioma risk as causally related to hormonal contraceptive use.
• Dose and duration dependence: Risk increases with longer use and with higher cumulative doses.
• Plausible mechanism: Progesterone promotes growth of existing meningioma tumors; synthetic progestins like Depo-Provera may trigger tumor development or acceleration.

Meningioma Symptoms and Medical Consequences

Meningiomas are tumors of the meninges (membranes surrounding the brain and spinal cord). Symptoms depend on tumor size and location:

• Persistent headaches: Often the first symptom; may progress in frequency and severity.
• Vision changes: Blurred vision, visual field defects, diplopia (double vision).
• Seizures: Caused by abnormal electrical activity triggered by the tumor.
• Cognitive impairment: Memory loss, difficulty concentrating, personality changes.
• Balance and coordination problems: Dizziness, ataxia, loss of proprioception.
• Motor weakness: Paralysis or paresis of limbs or facial muscles.
• Nausea and vomiting: Increased intracranial pressure.

Medical Treatment and Burden

• Treatment typically requires surgical resection, which carries significant risks:
• Brain surgery risks: Bleeding, infection, stroke, permanent neurological deficit.
• Radiation therapy: Often recommended post-surgery; increases risk of secondary tumors.
• Chemotherapy: For recurrent or malignant tumors.
• Lifelong surveillance: Repeat imaging to detect recurrence.
• Disability: Many women experience chronic neurological symptoms or cognitive impairment despite treatment.

Who May Qualify for a Depo-Provera Meningioma Claim?

• Women who used Depo-Provera continuously or intermittently for extended periods (typically 5+ years, though shorter durations may qualify).
• Diagnosis of meningioma (benign, atypical, or malignant; any grade).
• Medical records confirming Depo-Provera use and meningioma diagnosis.
• Temporal relationship: Tumor development during or within a reasonable latency period after Depo-Provera use.

Allegations Against Pfizer

We allege that Pfizer:

• Failed to adequately warn patients and providers about meningioma risk associated with Depo-Provera use.
• Inadequate labeling: Product insert downplayed or omitted neurological risks.
• Delayed response to scientific evidence: Despite published studies linking Depo-Provera to meningioma, Pfizer did not update warnings promptly.
• Prioritized commercial interests over patient safety.

Current Litigation Status

Depo-Provera meningioma litigation is still in early stages. Coordinated federal and state litigation is developing. Trial Lawyers United monitors scientific developments and welcomes inquiries from potentially affected women.

Frequently Asked Questions

I used Depo-Provera but stopped years ago. Can I still file a claim?

Yes. The statute of limitations typically begins when you discovered (or reasonably should have discovered) that your meningioma was caused by Depo-Provera. We evaluate each case individually.

My meningioma was benign. Can I still recover?

Absolutely. Benign meningiomas requiring surgery cause serious injury: neurological complications, cognitive impairment, disability, and the medical burden of neurosurgery and lifelong imaging surveillance. Injury is not limited to malignant tumors.

How do I prove causation — that Depo-Provera caused my tumor?

We retain neurosurgeons and neuro-oncologists to establish causation based on scientific literature, epidemiological evidence, and your individual medical timeline. Medical records documenting your Depo-Provera use dates and meningioma diagnosis are essential.

What compensation might I recover?

Recovery includes past and future medical expenses, lost income, pain and suffering, and in severe cases involving permanent disability, substantial damages. We estimate each case based on your specific injuries and prognosis.

Diagnosed with meningioma after Depo-Provera use?

• You may have a claim worth pursuing.
• Confidential case evaluation available.